Results 91 to 100 of about 974 (165)

Synthesis and pharmacological evaluation of several N-(2-nitrophenyl) piperazine derivatives [PDF]

Six newly synthesized heterocyclic (2-nitrophenyl)piperazines, with a specific structure of the heteroaryl group, whichmimics the catechol moiety of dopamine (benzimidazoles and substituted benzimidazoles), were evaluated for their binding affinity to ...
Andrić, Deana, Kostić-Rajačić, Slađana V., Roglić, Goran, Tomić, Mirko, Tovilović, Gordana, Vasković, Đurđica, Šoškić, Vukić   +6 more
core   +1 more source

Enantioseparation of Proton Pump Inhibitors by HPLC on Polysaccharide-Type Stationary Phases: Enantiomer Elution Order Reversal, Thermodynamic Characterization, and Hysteretic Effect. [PDF]

Int J Mol Sci
Dobó M, Molnár G, Mhammad A, Dombi G, Mirzahosseini A, Szabó ZI, Tóth G.   +6 more
europepmc   +1 more source

Measuring entomological parameters before implementing a study on asymptomatic carriers of Plasmodium falciparum in the Zè District in southern Benin. [PDF]

Malar J, 2023
Bouraima A, Djènontin A, Dossou Y, Houessou L, Soares C, Anato M, Zinsou BE, Dechavanne C, Clain J, Massougbodji A, Cottrell G.   +10 more
europepmc   +1 more source

The unexpected reduction of the vinyl-group of chlorophyll b by sodium borohydride in methanolic extracts of maize leaves and its inhibition by 8-Hydroxychinoline [PDF]

, 1993
Cmiel, Edmund, Katheder, Ingrid, Porra, R. J., Scheer, Hugo, Schäfer, W.   +4 more
core  

Predictive chemoproteomics and functional validation reveal Coeae6g-mediated insecticide cross-resistance in the malaria vector Anopheles gambiae. [PDF]

Nat Commun
Balaska S, Grigoraki L, Lycett G, Weetman D, Oladepo F, Colman F, Vontas J, Paine MJI, Ismail HM.   +8 more
europepmc   +1 more source

Phenotypic insecticide resistance status of the Culex pipiens complex: a European perspective. [PDF]

Parasit Vectors, 2022
Vereecken S, Vanslembrouck A, Kramer IM, Müller R.   +3 more
europepmc   +1 more source

Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. [PDF]

Nat Commun
Nordbeck P, Goker-Alpan O, Bernat JA, Germain DP, Giraldo P, Jovanovic A, Kimonis V, Nicholls K, Rockman-Greenberg C, Schiffmann R, Thomas M, Tylki-Szymanska A, Wallace E, Welford RWD, West ML, Clozel M, Frey A, Trokan L, Mueller MS, Vogler M, Wanner C, Hughes D.   +21 more
europepmc   +1 more source

Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic. [PDF]

FASEB J, 2023
Gelzinis JA, Szahaj MK, Bekendam RH, Wurl SE, Pantos MM, Verbetsky CA, Dufresne A, Shea M, Howard KC, Tsodikov OV, Garneau-Tsodikova S, Zwicker JI, Kennedy DR.   +12 more
europepmc   +1 more source

The impacts of indoor residual spraying with bendiocarb and pirimiphos-methyl on allelic frequencies of kdr and ace-1 mutations in central Senegal. [PDF]

Sci Rep
Diouf EH, Senghor MW, Sy MD, Ndiaye A, Konaté A, Niang O, Faye O, Dia I, Niang EHA, Konaté L.   +9 more
europepmc   +1 more source

Zafirlukast ameliorates Docetaxel-induced activation of NOD-like receptor protein 3 (NLRP3) inflammasome, mediated by sirtuin1 (SIRT1) in hepatocytes. [PDF]

Bioengineered, 2021
Guo Z, Zeng X, Zheng Y.
europepmc   +1 more source